The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 20, 2023
Filed:
Oct. 11, 2019
Applicant:
Lentigen Technology, Inc., Gaithersburg, MD (US);
Inventors:
Rimas J. Orentas, Seattle, WA (US);
Boro Dropulic, Ellicott City, MD (US);
Dina Schneider, Potomac, MD (US);
Assignee:
LENTIGEN TECHNOLOGY, INC., Gaithersburg, MD (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 48/00 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01); A61P 35/02 (2006.01); C07K 14/725 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2887 (2013.01); A61K 35/17 (2013.01); A61P 35/02 (2018.01); C07K 14/705 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 14/70578 (2013.01); C07K 16/2803 (2013.01); C07K 2317/31 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01);
Abstract
Chimeric antigen receptors containing CD19/CD20 or CD20/CD19 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.